These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy. Zaia JA; Chatterjee S; Wong KK; Elkins D; Taylor NR; Rossi JJ Ann N Y Acad Sci; 1992 Oct; 660():95-106. PubMed ID: 1340161 [No Abstract] [Full Text] [Related]
4. Can gene delivery close the door to HIV-1 entry after escape? Swan CH; Torbett BE J Med Primatol; 2006 Aug; 35(4-5):236-47. PubMed ID: 16872287 [TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Morris KV; Rossi JJ Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105 [TBL] [Abstract][Full Text] [Related]
6. Progress towards gene therapy for HIV infection. Yu M; Poeschla E; Wong-Staal F Gene Ther; 1994 Jan; 1(1):13-26. PubMed ID: 7584055 [TBL] [Abstract][Full Text] [Related]
7. Technology evaluation: StealthVector (HIV) Enzo. Günzburg W; Mhashilkar AM; Hindi M Curr Opin Mol Ther; 1999 Oct; 1(5):651-7. PubMed ID: 11249672 [TBL] [Abstract][Full Text] [Related]
8. Delivery of antisense DNA by vectors for prolonged effects in vitro and in vivo. Mohuczy D; Tang X; Phillips MI Methods Enzymol; 2000; 314():32-51. PubMed ID: 10565003 [No Abstract] [Full Text] [Related]
9. Development of ribozyme gene therapy for HIV infection. Wong-Staal F Antibiot Chemother (1971); 1996; 48():226-32. PubMed ID: 8726529 [No Abstract] [Full Text] [Related]
10. Current developments in anti-HIV/AIDS gene therapy. Tsygankov AY Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791 [TBL] [Abstract][Full Text] [Related]
11. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy. Bai J; Rossi J; Akkina R AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007 [TBL] [Abstract][Full Text] [Related]
12. A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins. Cooper D; Penny R; Symonds G; Carr A; Gerlach W; Sun LQ; Ely J Hum Gene Ther; 1999 May; 10(8):1401-21. PubMed ID: 10365669 [No Abstract] [Full Text] [Related]
13. Human immunodeficiency virus type I as a target for gene therapy. Gottfredsson M; Bohjanen PR Front Biosci; 1997 Dec; 2():d619-34. PubMed ID: 9388165 [TBL] [Abstract][Full Text] [Related]
14. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Amado RG; Mitsuyasu RT; Rosenblatt JD; Ngok FK; Bakker A; Cole S; Chorn N; Lin LS; Bristol G; Boyd MP; MacPherson JL; Fanning GC; Todd AV; Ely JA; Zack JA; Symonds GP Hum Gene Ther; 2004 Mar; 15(3):251-62. PubMed ID: 15018734 [TBL] [Abstract][Full Text] [Related]